Oculogica Portable EyeBOX Study

NCT ID: NCT05047003

Last Updated: 2023-09-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-12-19

Study Completion Date

2022-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to assess the accuracy of a portable version of the EyeBOX device, an eye-tracking based diagnostic, in comparison to a clinical reference standard of concussion. The utility of the portable assessment to aid in the monitoring of symptoms over time after an initial diagnosis of concussion will also be evaluated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Concussion, Brain Mild Traumatic Brain Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients under evaluation for Suspected Concussion

Device: EyeBOX Model EBX-4 (Portable version)

EyeBOX Model EBX-4 (Portable version)

Intervention Type DIAGNOSTIC_TEST

The portable EyeBOX takes less than 4 minutes to complete and involves watching a video move around the perimeter of an LCD monitor positioned in front of the patient while a high-speed camera continuously records gaze positions. The Portable EyeBOX software detects subtle changes in eye movements consistent with concussion and calculates a BOX score.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EyeBOX Model EBX-4 (Portable version)

The portable EyeBOX takes less than 4 minutes to complete and involves watching a video move around the perimeter of an LCD monitor positioned in front of the patient while a high-speed camera continuously records gaze positions. The Portable EyeBOX software detects subtle changes in eye movements consistent with concussion and calculates a BOX score.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1\. Provide documented informed consent or assent along with guardian consent.
* 2\. Have presented, at any time post injury, for any complaint related to an injury involving either a direct force to the head or a blow to the body that has the potential to transmit a rapid acceleration/deceleration of the head, with or without loss of consciousness, with or without external signs of head injury.
* 3\. Be 5 to 67 years of age, inclusive.
* 4\. Have the ability to provide a complete ophthalmologic, medical, and neurologic history as well as report current medications.

Exclusion Criteria

* 1\. Have penetrating trauma or known skull fracture or intracranial injury.
* 2\. Have had a conventional head CT or MRI demonstrating evidence of structural brain injury (subdural, epidural or intraparenchymal hemorrhage, edema/mass effect per attending radiologist read).
* 3\. Any of the following conditions, immediately related to the incident injury: loss of consciousness exceeding 30 minutes or best available Glasgow Coma Scale (GCS) score less than 13 within 24 hours or other acute conditions requiring emergency medical management.
* 4\. Be blind (no light perception), have missing or non-functional eyes.
* 5\. Be unable to open their eyes.
* 6\. Have a history of unresolved strabismus, diplopia, amblyopia.
* 7\. Have a history of unresolved cranial nerve III, IV, or VI palsy.
* 8\. Have a history of unresolved macular edema, retinal degeneration, extensive cataract, or ocular globe disruption.
* 9\. Have a history of extensive prior eye surgery or scarring (examples include strabismus surgery, scleral buckle repair of retinal detachment, repair of blow out fractures of the orbit and any procedures that would interfere with extraocular muscle movements; prior cataract surgery or Lasik are not exclusions).
* 10\. Have a prior history of unresolved ocular-motor dysfunctions.
* 11\. Be intoxicated.
Minimum Eligible Age

5 Years

Maximum Eligible Age

67 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Oculogica, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rosina Samadani, PhD

Role: STUDY_DIRECTOR

Oculogica, Inc.

Amy Romandine-Kratz, MD

Role: PRINCIPAL_INVESTIGATOR

Prevea Health

Mario Chavez, DC

Role: PRINCIPAL_INVESTIGATOR

Redlands Chiropractic

Brian Lease, PT

Role: PRINCIPAL_INVESTIGATOR

Westfields Hospital

Yang K Lo, MD

Role: PRINCIPAL_INVESTIGATOR

CentraCare

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Redlands Chiropractic

Redlands, California, United States

Site Status

CentraCare

Saint Cloud, Minnesota, United States

Site Status

Prevea Health

Green Bay, Wisconsin, United States

Site Status

Westfields Hospital

New Richmond, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MTBI003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.